As with SLC5A8, GPR109A may also undergo DNA methylation in colon cancer, but GPR109A can be re-expressed in colon cancer cells in the presence of butyrate, leading to the death of tumor cells [161]. Here, SLC5A8 is linked to malignant colon neoplasm.